Received Jul 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (NOVAVAX)) | NOVAVAX | UNK | — | OT |
Daughter received the 2024-2025 Novavax vaccine but just one dose; Daughter received the 2024-2025 Novavax vaccine but just one dose; This non-serious initial spontaneous report was reported by a consumer or other non health professional and concerns a female of unspecified age who experienced DAUGHTER RECEIVED THE 2024-2025 NOVAVAX VACCINE BUT JUST ONE DOSE (PT: Incomplete course of vaccination) and DAUGHTER RECEIVED THE 2024-2025 NOVAVAX VACCINE BUT JUST ONE DOSE (PT: Off label use) after receiving Novavax COVID-19 Vaccine, Adjuvanted (2024 - 2025 Formula). At the time of the report, the outcome of the Incomplete course of vaccination, Off label use was Recovered/Resolved.; Sender's Comments: This Female of unspecified age experienced Incomplete course of vaccination and Off label use after vaccination with Novavax COVID-19 Vaccine, Adjuvanted (2024 - 2025 Formula). The events Incomplete course of vaccination and Off label use were reported as non-serious. Based on the spontaneous nature of the report, the causal relationship between Novavax COVID-19 Vaccine, Adjuvanted (2024 - 2025 Formula) and Incomplete course of vaccination and Off label use is considered Possible.